nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—MTOR—forelimb—amyotrophic lateral sclerosis	0.0364	0.183	CbGeAlD
Temsirolimus—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0346	0.0525	CcSEcCtD
Temsirolimus—MTOR—hindlimb—amyotrophic lateral sclerosis	0.0327	0.165	CbGeAlD
Temsirolimus—MTOR—appendage—amyotrophic lateral sclerosis	0.0281	0.142	CbGeAlD
Temsirolimus—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0276	CcSEcCtD
Temsirolimus—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0268	CcSEcCtD
Temsirolimus—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0242	CcSEcCtD
Temsirolimus—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0231	CcSEcCtD
Temsirolimus—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0231	CcSEcCtD
Temsirolimus—MTOR—hindbrain—amyotrophic lateral sclerosis	0.0149	0.0751	CbGeAlD
Temsirolimus—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0199	CcSEcCtD
Temsirolimus—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0194	CcSEcCtD
Temsirolimus—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0194	CcSEcCtD
Temsirolimus—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0125	0.019	CcSEcCtD
Temsirolimus—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0179	CcSEcCtD
Temsirolimus—Abscess—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0173	CcSEcCtD
Temsirolimus—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0169	CcSEcCtD
Temsirolimus—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.011	0.0167	CcSEcCtD
Temsirolimus—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00994	0.0151	CcSEcCtD
Temsirolimus—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00981	0.0149	CcSEcCtD
Temsirolimus—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00955	0.0145	CcSEcCtD
Temsirolimus—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00955	0.0145	CcSEcCtD
Temsirolimus—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00949	0.0144	CcSEcCtD
Temsirolimus—MTOR—embryo—amyotrophic lateral sclerosis	0.00932	0.047	CbGeAlD
Temsirolimus—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00904	0.0137	CcSEcCtD
Temsirolimus—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00904	0.0137	CcSEcCtD
Temsirolimus—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00863	0.0131	CcSEcCtD
Temsirolimus—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00858	0.013	CcSEcCtD
Temsirolimus—MTOR—brainstem—amyotrophic lateral sclerosis	0.00854	0.0431	CbGeAlD
Temsirolimus—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00817	0.0124	CcSEcCtD
Temsirolimus—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00784	0.0119	CcSEcCtD
Temsirolimus—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0114	CcSEcCtD
Temsirolimus—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0114	CcSEcCtD
Temsirolimus—Eczema—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0111	CcSEcCtD
Temsirolimus—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00695	0.0106	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00656	0.00996	CcSEcCtD
Temsirolimus—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00633	0.00961	CcSEcCtD
Temsirolimus—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0061	0.00926	CcSEcCtD
Temsirolimus—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00597	0.00906	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00591	0.00897	CcSEcCtD
Temsirolimus—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00581	0.00881	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00579	0.00878	CcSEcCtD
Temsirolimus—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00571	0.00866	CcSEcCtD
Temsirolimus—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00567	0.0086	CcSEcCtD
Temsirolimus—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00567	0.0086	CcSEcCtD
Temsirolimus—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00545	0.00828	CcSEcCtD
Temsirolimus—FKBP1A—medulla oblongata—amyotrophic lateral sclerosis	0.00535	0.027	CbGeAlD
Temsirolimus—MTOR—spinal cord—amyotrophic lateral sclerosis	0.00531	0.0268	CbGeAlD
Temsirolimus—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00805	CcSEcCtD
Temsirolimus—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00805	CcSEcCtD
Temsirolimus—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00795	CcSEcCtD
Temsirolimus—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00779	CcSEcCtD
Temsirolimus—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00508	0.00772	CcSEcCtD
Temsirolimus—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00767	CcSEcCtD
Temsirolimus—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00767	CcSEcCtD
Temsirolimus—Depression—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00765	CcSEcCtD
Temsirolimus—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00748	CcSEcCtD
Temsirolimus—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00746	CcSEcCtD
Temsirolimus—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00482	0.00732	CcSEcCtD
Temsirolimus—FKBP1A—spinal cord—amyotrophic lateral sclerosis	0.00477	0.0241	CbGeAlD
Temsirolimus—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00477	0.00724	CcSEcCtD
Temsirolimus—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0072	CcSEcCtD
Temsirolimus—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00691	CcSEcCtD
Temsirolimus—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0045	0.00684	CcSEcCtD
Temsirolimus—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0068	CcSEcCtD
Temsirolimus—MTOR—nervous system—amyotrophic lateral sclerosis	0.00447	0.0226	CbGeAlD
Temsirolimus—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00679	CcSEcCtD
Temsirolimus—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00677	CcSEcCtD
Temsirolimus—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00675	CcSEcCtD
Temsirolimus—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00431	0.0217	CbGeAlD
Temsirolimus—MTOR—central nervous system—amyotrophic lateral sclerosis	0.00431	0.0217	CbGeAlD
Temsirolimus—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00651	CcSEcCtD
Temsirolimus—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00644	CcSEcCtD
Temsirolimus—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00639	CcSEcCtD
Temsirolimus—MTOR—cerebellum—amyotrophic lateral sclerosis	0.00421	0.0212	CbGeAlD
Temsirolimus—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00625	CcSEcCtD
Temsirolimus—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00622	CcSEcCtD
Temsirolimus—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00621	CcSEcCtD
Temsirolimus—Chills—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00618	CcSEcCtD
Temsirolimus—FKBP1A—nervous system—amyotrophic lateral sclerosis	0.00402	0.0203	CbGeAlD
Temsirolimus—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00603	CcSEcCtD
Temsirolimus—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00395	0.006	CcSEcCtD
Temsirolimus—FKBP1A—central nervous system—amyotrophic lateral sclerosis	0.00387	0.0195	CbGeAlD
Temsirolimus—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00587	CcSEcCtD
Temsirolimus—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0058	CcSEcCtD
Temsirolimus—FKBP1A—cerebellum—amyotrophic lateral sclerosis	0.00379	0.0191	CbGeAlD
Temsirolimus—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00554	CcSEcCtD
Temsirolimus—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00548	CcSEcCtD
Temsirolimus—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00537	CcSEcCtD
Temsirolimus—Cough—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00523	CcSEcCtD
Temsirolimus—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00519	CcSEcCtD
Temsirolimus—MTOR—brain—amyotrophic lateral sclerosis	0.00342	0.0172	CbGeAlD
Temsirolimus—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00518	CcSEcCtD
Temsirolimus—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00336	0.0051	CcSEcCtD
Temsirolimus—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00336	0.0051	CcSEcCtD
Temsirolimus—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00336	0.0051	CcSEcCtD
Temsirolimus—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00509	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00507	CcSEcCtD
Temsirolimus—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00489	CcSEcCtD
Temsirolimus—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00489	CcSEcCtD
Temsirolimus—Infection—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00486	CcSEcCtD
Temsirolimus—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0048	CcSEcCtD
Temsirolimus—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00479	CcSEcCtD
Temsirolimus—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00475	CcSEcCtD
Temsirolimus—FKBP1A—brain—amyotrophic lateral sclerosis	0.00308	0.0155	CbGeAlD
Temsirolimus—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00466	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00446	CcSEcCtD
Temsirolimus—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00443	CcSEcCtD
Temsirolimus—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00436	CcSEcCtD
Temsirolimus—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00435	CcSEcCtD
Temsirolimus—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00425	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00422	CcSEcCtD
Temsirolimus—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00422	CcSEcCtD
Temsirolimus—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00418	CcSEcCtD
Temsirolimus—Pain—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00418	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00264	0.004	CcSEcCtD
Temsirolimus—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00387	CcSEcCtD
Temsirolimus—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00387	CcSEcCtD
Temsirolimus—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00247	0.0125	CbGeAlD
Temsirolimus—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00361	CcSEcCtD
Temsirolimus—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00351	CcSEcCtD
Temsirolimus—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00346	CcSEcCtD
Temsirolimus—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00335	CcSEcCtD
Temsirolimus—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00324	CcSEcCtD
Temsirolimus—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00311	CcSEcCtD
Temsirolimus—Rash—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00309	CcSEcCtD
Temsirolimus—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00308	CcSEcCtD
Temsirolimus—Headache—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00307	CcSEcCtD
Temsirolimus—ABCB1—embryo—amyotrophic lateral sclerosis	0.00194	0.00978	CbGeAlD
Temsirolimus—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00291	CcSEcCtD
Temsirolimus—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00131	0.00663	CbGeAlD
Temsirolimus—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00129	0.00653	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00127	0.00638	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00628	CbGeAlD
Temsirolimus—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00124	0.00625	CbGeAlD
Temsirolimus—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00122	0.00614	CbGeAlD
Temsirolimus—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.0011	0.00557	CbGeAlD
Temsirolimus—CYP2D6—brain—amyotrophic lateral sclerosis	0.000989	0.00499	CbGeAlD
Temsirolimus—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000931	0.00469	CbGeAlD
Temsirolimus—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000896	0.00452	CbGeAlD
Temsirolimus—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000876	0.00442	CbGeAlD
Temsirolimus—ABCB1—brain—amyotrophic lateral sclerosis	0.000711	0.00359	CbGeAlD
Temsirolimus—MTOR—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000675	0.00473	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB4—amyotrophic lateral sclerosis	0.000665	0.00465	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—CASP9—amyotrophic lateral sclerosis	0.000613	0.00429	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00061	0.00427	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—VTA1—amyotrophic lateral sclerosis	0.000596	0.00417	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—CASP9—amyotrophic lateral sclerosis	0.000587	0.00411	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000584	0.00409	CbGpPWpGaD
Temsirolimus—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000584	0.00409	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000581	0.00407	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.000578	0.00404	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—ATF1—amyotrophic lateral sclerosis	0.000576	0.00404	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.00057	0.00399	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000567	0.00397	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—CASP9—amyotrophic lateral sclerosis	0.000552	0.00386	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—CASP9—amyotrophic lateral sclerosis	0.000549	0.00384	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—CASP9—amyotrophic lateral sclerosis	0.000546	0.00382	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—CASP9—amyotrophic lateral sclerosis	0.000543	0.00381	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CASP9—amyotrophic lateral sclerosis	0.000536	0.00375	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.00053	0.00371	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.000525	0.00368	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000524	0.00367	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CASP9—amyotrophic lateral sclerosis	0.000511	0.00358	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—CASP9—amyotrophic lateral sclerosis	0.000511	0.00358	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—CASP9—amyotrophic lateral sclerosis	0.000511	0.00358	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000508	0.00356	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.000508	0.00356	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—CASP9—amyotrophic lateral sclerosis	0.000507	0.00355	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—ERBB4—amyotrophic lateral sclerosis	0.000502	0.00352	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—CASP9—amyotrophic lateral sclerosis	0.000502	0.00352	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.0005	0.0035	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—CASP9—amyotrophic lateral sclerosis	0.0005	0.0035	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000494	0.00346	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IGF1—amyotrophic lateral sclerosis	0.000485	0.0034	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00048	0.00336	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000475	0.00333	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CASP9—amyotrophic lateral sclerosis	0.000473	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IGF1—amyotrophic lateral sclerosis	0.000472	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—ERBB4—amyotrophic lateral sclerosis	0.000472	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—ERBB4—amyotrophic lateral sclerosis	0.00047	0.00329	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000468	0.00328	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.000467	0.00327	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	0.000465	0.00326	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.000458	0.00321	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CASP9—amyotrophic lateral sclerosis	0.000453	0.00317	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000452	0.00316	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—ERBB4—amyotrophic lateral sclerosis	0.000438	0.00306	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	0.000438	0.00306	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.000438	0.00306	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.000434	0.00304	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.00043	0.00301	CbGpPWpGaD
Temsirolimus—MTOR—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.000428	0.003	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.000428	0.003	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000427	0.00299	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IGF1—amyotrophic lateral sclerosis	0.000425	0.00297	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.00042	0.00294	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TPK1—amyotrophic lateral sclerosis	0.000419	0.00294	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000415	0.00291	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PLB1—amyotrophic lateral sclerosis	0.000408	0.00286	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—VEGFA—amyotrophic lateral sclerosis	0.000407	0.00285	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.000405	0.00284	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.00039	0.00273	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000388	0.00272	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.000388	0.00271	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—MMP9—amyotrophic lateral sclerosis	0.000369	0.00259	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000366	0.00256	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—VCP—amyotrophic lateral sclerosis	0.000364	0.00255	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000362	0.00253	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00036	0.00252	CbGpPWpGaD
Temsirolimus—MTOR—ErbB Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000357	0.0025	CbGpPWpGaD
Temsirolimus—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000357	0.0025	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000348	0.00244	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000344	0.00241	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.00034	0.00238	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000338	0.00237	CbGpPWpGaD
Temsirolimus—MTOR—Disease—VTA1—amyotrophic lateral sclerosis	0.000335	0.00235	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.000334	0.00234	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000333	0.00233	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000325	0.00228	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000308	0.00215	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000306	0.00214	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000298	0.00209	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000298	0.00209	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000294	0.00206	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000293	0.00205	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000286	0.002	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000285	0.00199	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000277	0.00194	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000277	0.00194	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—VEGFA—amyotrophic lateral sclerosis	0.000273	0.00191	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000272	0.0019	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000269	0.00188	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000268	0.00188	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000261	0.00183	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CST3—amyotrophic lateral sclerosis	0.000261	0.00183	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	0.000258	0.00181	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000258	0.00181	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000255	0.00178	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000254	0.00178	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000254	0.00178	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000253	0.00177	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000247	0.00173	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000245	0.00171	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000245	0.00171	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000244	0.00171	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000236	0.00165	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000231	0.00162	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PLB1—amyotrophic lateral sclerosis	0.00023	0.00161	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000222	0.00155	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000219	0.00153	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000217	0.00152	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—amyotrophic lateral sclerosis	0.00021	0.00147	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000209	0.00146	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000207	0.00145	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000207	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Disease—VCP—amyotrophic lateral sclerosis	0.000205	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000203	0.00142	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.0002	0.0014	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0002	0.0014	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0002	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000199	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000191	0.00134	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CASP9—amyotrophic lateral sclerosis	0.00019	0.00133	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000186	0.0013	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000183	0.00128	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000183	0.00128	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000177	0.00124	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000175	0.00122	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000173	0.00121	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00017	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.00017	0.00119	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000167	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000163	0.00114	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ERBB4—amyotrophic lateral sclerosis	0.000163	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000161	0.00113	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00016	0.00112	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000158	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000157	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000154	0.00108	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000152	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000151	0.00106	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000151	0.00106	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000151	0.00106	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.00015	0.00105	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000149	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CST3—amyotrophic lateral sclerosis	0.000147	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000147	0.00103	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000145	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000143	0.001	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000142	0.000997	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000142	0.000997	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000141	0.000989	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.00014	0.000981	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00014	0.000978	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000139	0.000972	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000138	0.000968	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000136	0.00095	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000134	0.000938	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000134	0.000938	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000133	0.000931	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.000133	0.000929	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00013	0.000912	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.00013	0.000907	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000129	0.0009	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—APOE—amyotrophic lateral sclerosis	0.000126	0.000881	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000123	0.000863	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000122	0.000854	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000122	0.000851	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ATF1—amyotrophic lateral sclerosis	0.000121	0.000851	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000121	0.000848	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000121	0.000846	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00012	0.000839	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000119	0.000836	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CASP9—amyotrophic lateral sclerosis	0.000116	0.00081	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000115	0.000806	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000114	0.000797	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000114	0.000797	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000113	0.000793	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00011	0.000768	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000109	0.000765	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000107	0.00075	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CASP9—amyotrophic lateral sclerosis	0.000107	0.000748	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000103	0.000721	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000101	0.000709	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.0001	0.000702	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ERBB4—amyotrophic lateral sclerosis	9.9e-05	0.000694	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.46e-05	0.000662	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	9.4e-05	0.000658	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	9.31e-05	0.000652	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	9.31e-05	0.000652	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—amyotrophic lateral sclerosis	9.31e-05	0.000652	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ERBB4—amyotrophic lateral sclerosis	9.14e-05	0.00064	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.81e-05	0.000617	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.72e-05	0.000611	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—amyotrophic lateral sclerosis	8.62e-05	0.000603	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.52e-05	0.000596	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.38e-05	0.000586	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	8.32e-05	0.000582	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.28e-05	0.00058	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—C3—amyotrophic lateral sclerosis	8.23e-05	0.000576	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.92e-05	0.000554	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.85e-05	0.00055	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	7.8e-05	0.000546	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	7.64e-05	0.000535	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.48e-05	0.000524	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.44e-05	0.000521	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.4e-05	0.000518	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.28e-05	0.00051	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	7.2e-05	0.000504	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOE—amyotrophic lateral sclerosis	7.07e-05	0.000495	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	6.73e-05	0.000471	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.4e-05	0.000448	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.28e-05	0.000439	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.18e-05	0.000433	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.02e-05	0.000422	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	5.91e-05	0.000414	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.68e-05	0.000398	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.6e-05	0.000392	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.59e-05	0.000392	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.32e-05	0.000373	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.29e-05	0.000371	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.1e-05	0.000357	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.95e-05	0.000347	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—amyotrophic lateral sclerosis	4.85e-05	0.000339	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.75e-05	0.000333	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.71e-05	0.00033	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	4.68e-05	0.000327	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.47e-05	0.000313	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.11e-05	0.000288	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.09e-05	0.000287	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.87e-05	0.000271	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.59e-05	0.000252	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	3.38e-05	0.000237	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.37e-05	0.000236	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.2e-05	0.000224	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.18e-05	0.000223	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.15e-05	0.000221	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.1e-05	0.000217	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.98e-05	0.000208	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.92e-05	0.000205	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.67e-05	0.000187	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.55e-05	0.000179	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.4e-05	0.000168	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.32e-05	0.000162	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.08e-05	0.000146	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.02e-05	0.000141	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.91e-05	0.000134	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.75e-05	0.000122	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.65e-05	0.000115	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.57e-05	0.00011	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.08e-05	7.54e-05	CbGpPWpGaD
